聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 41 分钟 20 秒 前

Specialty Vaccine Company PaxVax Expands Global Commercial Team

周四, 08/07/2014 - 15:10
REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--PaxVax, Inc., a specialty vaccine company focused on travel and biodefense, today announced the expansion of its global commercial team with the appointments of Jonathan Klock as Vice President ...
Biopharmaceuticals, Personnel
PaxVax, vaccine, Vivotif, typhoid, cholera, anthrax

Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization

周四, 08/07/2014 - 15:07
Veteran Medical Device Executive with Expertise in Clinical, Reimbursement, Sales, Marketing REDWOOD CITY, Calif.--(Healthcare Sales & Marketing Network)--Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive so...
Devices, Personnel
Gynesonics, uterine fibroids, VizAblate

OncoGenex Pharmaceuticals Announces Appointment of John A. Bencich as Vice President and Chief Financial Officer

周四, 08/07/2014 - 15:00
BOTHELL, Wash. and VANCOUVER, British Columbia , Aug. 7, 2014 (Healthcare Sales & Marketing Network) -- OncoGenex Pharmaceuticals, Inc. (OGXI) today announced the appointment of John A. Bencich as Vice President and Chief Financial Officer (CFO). John B...
Biopharmaceuticals, Oncology, Personnel
OncoGenex Pharmaceuticals, custirsen, prostate cancer

Cortendo Appoints Matthew Pauls as Chief Executive Officer

周四, 08/07/2014 - 14:57
GÖTEBORG, Sweden--(Healthcare Sales & Marketing Network)--Cortendo AB (OSE:CORT) announces the appointment of Matthew Pauls as President and Chief Executive Officer effective Monday, August 25, 2014. Mr. Pauls brings to Cortendo more than 20 years ...
Biopharmaceuticals, Endocrinology, Personnel
Cortendo, NormoCort, cortisol, Cushing’s Syndrome

BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes

周三, 08/06/2014 - 15:20
The only pen needle with patented dual needle shields for enhanced convenience and safety is latest BD innovation for insulin injection FRANKLIN LAKES, N.J., Aug. 6, 2014 -- (Healthcare Sales & Marketing Network) -- BD Medical, a segment of BD (Becton,...
Devices, Drug Delivery, Endocrinology, Product Launch
BD , AutoShield, needle, diabetes

Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer

周三, 08/06/2014 - 15:15
SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Nodality, Inc., an innovative biotechnology company advancing discovery, development and use of transformative therapies across broad therapeutic categories, with a focus on immunology an...
Biopharmaceuticals, Personnel
Nodality, Single Cell Network Profiling

Tufts Medical Center and ATON Partners Announce Formation of CereVasc, LLC

周三, 08/06/2014 - 12:23
Development Stage Company to Focus on Breakthrough Treatments of Neurological Diseases BOSTON, Aug. 6, 2014 -- (Healthcare Sales & Marketing Network) -- Tufts Medical Center and ATON Partners, LLC today announced the formation of CereVasc, LLC, a rese...
Devices, Neurosurgery
ATON Partners, CereVasc , hydrocephalus

Synta Names Anne Whitaker Chief Executive Officer

周三, 08/06/2014 - 12:16
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Synta Pharmaceuticals Corp. (SNTA) today announced that Anne Whitaker will join the Company as President, Chief Executive Officer and a member of the Company’s Board of Directors effective September...
Biopharmaceuticals, Personnel
Synta Pharmaceuticals

Akebia Therapeutics Announces Expansion of Management Team

周三, 08/06/2014 - 12:13
Key additions will help drive strategic growth and advance lead clinical programs CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Akebia Therapeutics, Inc. (AKBA), a biopharmaceutical company focused on harnessing the potential of hypoxia-indu...
Biopharmaceuticals, Personnel
Akebia Therapeutics, hypoxia-inducible factor

FDA Approves the SynCardia Total Artificial Heart With SynHall Valves

周二, 08/05/2014 - 17:01
SynCardia Systems, Inc., now controls last key component in heart manufacturing TUCSON, Ariz., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- SynCardia Systems, Inc. received approval July 2, 2014 from the United States Federal Drug Administ...
Devices, Cardiology, FDA
SynCardia Systems, Total Artificial Heart, SynHall valve

IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery

周二, 08/05/2014 - 16:57
100% Local (Resection Cavity) Freedom From Progression With 19.3 Month Median Follow-Up RICHLAND, WA--(Healthcare Sales & Marketing Network) - IsoRay Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radi...
Devices, Neurosurgery, Oncology
IsoRay, Cesium-131, brachytherapy, brain cancer, radiotherapy

EDAP Comments on FDA Panel Vote

周二, 08/05/2014 - 16:52
Responds to Gastroenterology and Urology Devices Panel Vote on Ablatherm-HIFU for Treatment of Prostate Cancer LYON, France, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- EDAP TMS SA (EDAP), the global leader in therapeutic ultrasound, today...
Devices, Oncology, FDA
EDAP TMS, Ablatherm, high-intensity focused ultrasound, prostate cancer

CardioMEMS Heart Failure Monitoring System Receives Approval from CMS for New Technology Add-On Payment

周二, 08/05/2014 - 16:48
St. Jude Medical’s CardioMEMS HF System demonstrates our commitment to delivering high-quality, innovative solutions that reduce health care costs and improve outcomes for patients ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medic...
Devices, Cardiology, Reimbursement
St. Jude Medical, CardioMEMS, pulmonary artery pressure

Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors

周二, 08/05/2014 - 16:44
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Alzheon, Inc., a clinical-stage biopharmaceutical company focused on brain health, memory and aging, announced today that it has appointed Jean-Pierre Sommadossi, PhD, to the company’s Board of Dire...
Biopharmaceuticals, Neurology, Personnel
Alzheon, ALZ-801, Alzheimer’s disease

MELA Sciences Names Michael R. Stewart to Board of Directors

周二, 08/05/2014 - 16:41
Stewart Brings to MELA a Wealth of Dermatological Medical Device Expertise Across All Aspects of the Business IRVINGTON, N.Y., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- MELA Sciences, Inc. (MELA), developer of the MelaFind(R) system, an ...
Devices, Diagnostics, Oncology, Dermatology, Personnel
MELA Sciences, MelaFind, melanoma

Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market

周二, 08/05/2014 - 12:25
QUÉBEC CITY, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) - Aeterna Zentaris Inc. (AEZS) (TSX: AEZ) (the "Company") today announced a strategic co-promotion services agreement with ASCEND Therapeutics® US, LLC, ("ASCEND...
Biopharmaceuticals, Distribution
Aeterna Zentaris, ASCEND Therapeutics, EstroGel, Macrilen

Boston Therapeutics Expands Medical Advisory Board

周二, 08/05/2014 - 12:20
Noted Diabetes Experts Meng H Tan, M.D., Philip Raskin, M.D., and Charles M. Clark, Jr., M.D. to Serve as Medical Advisory Board Members MANCHESTER, NH--(Healthcare Sales & Marketing Network)) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Ther...
Biopharmaceuticals, Personnel
Boston Therapeutics

TesoRx Closes $10M in Funding, Secures Key Patent and Hires Renowned Urologist as Chief Medical Officer

周二, 08/05/2014 - 12:15
MENLO PARK, Calif., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- TesoRx Pharma, LLC., a specialty pharmaceutical company focused on rapidly developing and commercializing products in specialty and niche markets, announced today that it has cl...
Biopharmaceuticals, Personnel, Venture Capital
TesoRx Pharma

Caris Molecular Intelligence(TM) Identifies Key Biomarkers of Clinical Benefit and Resistance to Chemotherapy through Multi-Technology Tumor Profiling

周二, 08/05/2014 - 12:11
Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Caris Life Scien...
Diagnostics, Oncology
Caris Life Sciences, Molecular Intelligence, tumor profiling

Akers Appoints New Vice President of International Sales and Marketing to Build International Business

周二, 08/05/2014 - 12:04
THOROFARE, N.J., Aug. 5, 2014 -- (Healthcare Sales & Marketing Network) -- Akers Biosciences, Inc. (AKER) (AKR.L) (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and testing products, announ...
Diagnostics, Personnel
Akers Biosciences

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong